These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35965458)

  • 1. Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions.
    Panovska-Griffiths J; Swallow B; Hinch R; Cohen J; Rosenfeld K; Stuart RM; Ferretti L; Di Lauro F; Wymant C; Izzo A; Waites W; Viner R; Bonell C; Fraser C; Klein D; Kerr CC;
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210315. PubMed ID: 35965458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating SARS-CoV-2 variant fitness and the impact of interventions in England using statistical and geo-spatial agent-based models.
    Hinch R; Panovska-Griffiths J; Probert WJM; Ferretti L; Wymant C; Di Lauro F; Baya N; Ghafari M; Abeler-Dörner L; ; Fraser C
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210304. PubMed ID: 35965459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
    Sanz-Leon P; Hamilton LHW; Raison SJ; Pan AJX; Stevenson NJ; Stuart RM; Abeysuriya RG; Kerr CC; Lambert SB; Roberts JA
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210311. PubMed ID: 35965469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.
    Earnest R; Uddin R; Matluk N; Renzette N; Turbett SE; Siddle KJ; Loreth C; Adams G; Tomkins-Tinch CH; Petrone ME; Rothman JE; Breban MI; Koch RT; Billig K; Fauver JR; Vogels CBF; Bilguvar K; De Kumar B; Landry ML; Peaper DR; Kelly K; Omerza G; Grieser H; Meak S; Martha J; Dewey HB; Kales S; Berenzy D; Carpenter-Azevedo K; King E; Huard RC; Novitsky V; Howison M; Darpolor J; Manne A; Kantor R; Smole SC; Brown CM; Fink T; Lang AS; Gallagher GR; Pitzer VE; Sabeti PC; Gabriel S; MacInnis BL; ; Tewhey R; Adams MD; Park DJ; Lemieux JE; Grubaugh ND
    Cell Rep Med; 2022 Apr; 3(4):100583. PubMed ID: 35480627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons drawn from Shanghai for controlling highly transmissible SARS-CoV-2 variants: insights from a modelling study.
    Wang H; Li T; Gao H; Huang C; Tang B; Tang S; Cheke RA; Zhou W
    BMC Infect Dis; 2023 May; 23(1):331. PubMed ID: 37194011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England.
    Eales O; de Oliveira Martins L; Page AJ; Wang H; Bodinier B; Tang D; Haw D; Jonnerby J; Atchison C; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Elliott P; Donnelly CA; Chadeau-Hyam M
    Nat Commun; 2022 Jul; 13(1):4375. PubMed ID: 35902613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covasim: An agent-based model of COVID-19 dynamics and interventions.
    Kerr CC; Stuart RM; Mistry D; Abeysuriya RG; Rosenfeld K; Hart GR; Núñez RC; Cohen JA; Selvaraj P; Hagedorn B; George L; Jastrzębski M; Izzo AS; Fowler G; Palmer A; Delport D; Scott N; Kelly SL; Bennette CS; Wagner BG; Chang ST; Oron AP; Wenger EA; Panovska-Griffiths J; Famulare M; Klein DJ
    PLoS Comput Biol; 2021 Jul; 17(7):e1009149. PubMed ID: 34310589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact of reopening schools in the UK in early 2021 in the presence of the alpha variant and with roll-out of vaccination against SARS-CoV-2.
    Panovska-Griffiths J; Stuart RM; Kerr CC; Rosenfield K; Mistry D; Waites W; Klein DJ; Bonell C; Viner RM
    J Math Anal Appl; 2022 Oct; 514(2):126050. PubMed ID: 35153332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining epidemiological forecasts with simple scoring rules.
    Moore RE; Rosato C; Maskell S
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210305. PubMed ID: 35965461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
    Yu Y; Yu Y; Zhao S; He D
    Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical challenges of modelling real-life epidemics and examples of overcoming these.
    Panovska-Griffiths J; Waites W; Ackland GJ
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20220179. PubMed ID: 35965472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.